New Clinical Trials for Atrial Fibrillation

Enroll in a Clinical Trial for Atrial FibrillationAtrial fibrillation clinical studies focus on many aspects of the disease. Some study ways to prevent it while others look at managing it in order to prevent it from resulting in more severe conditions such as stroke and heart failure. If you have been diagnosed with atrial fibrillation you are most likely an excellent candidate to take part in a clinical trial.

If you feel that you may qualify and are interested in participating in a current atrial fibrillation clinical trial, please review the list below. Participation in clinical trials is always at no cost to you.

What is Atrial Fibrillation?

Atrial fibrillation is the most common form of an abnormal heart rhythm. It occurs when heart muscles quiver rather than pump blood in rhythmic contractions. Atrial fibrillation in itself may not be detectable or dangerous to a patient, but it is an indication of possible future ailments such as stroke, heart failure and palpitations. Atrial fibrillation can sometimes be detected by taking a pulse and an EKG will also reveal it. The risk of developing atrial fibrillation increases with age and the condition tends to become chronic.

Atrial Fibrillation Treatments

The main goal in treating atrial fibrillation is to prevent instability in the circulatory system that could ultimately lead to a stroke. When blood is not being pumped correctly it can pool and clot. It is sometimes treated with anticoagulation medications such as aspirin that help prevent blood from clotting. Atrial fibrillation treatments also include rate control and rhythm control. Rate control reduces the heart rate to a normal one while rhythm control aims to regulate the rhythm of the heart beat. Another available treatment is called cardioversion. Cardioversion uses either electric shock or chemicals to regulate the heart beat.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,554 Atrial Fibrillation
clinical trials

Cardiology / Vascular Diseases, Other Clinical Trial
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Status: Enrolling
Updated: 7/14/2015
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 9/14/2015
mi
from
Boston, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 9/14/2015
mi
from
Portland, OR
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 9/14/2015
mi
from
Aurora, CO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 9/14/2015
mi
from
Camden, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 9/14/2015
mi
from
Charlotte, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 9/14/2015
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 9/14/2015
mi
from
Detroit, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 9/14/2015
mi
from
Evanston, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 9/14/2015
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 9/14/2015
mi
from
Jackson, MS
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 9/14/2015
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 9/14/2015
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 9/14/2015
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 9/14/2015
mi
from
San Antonio, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 9/14/2015
mi
from
Tulsa, OK
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
nContactSurgical Numeris-AF Tethered Coagulation System for Treatment of Persistent & LSP AF
Status: Enrolling
Updated: 4/22/2013
mi
from
Memphis, TN
Click here to add this to my saved trials
Paroxysmal Atrial Fibrillation Clinical Trial
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling, Phase IV
Updated: 3/21/2012
mi
from
Boston, MA
Click here to add this to my saved trials
Paroxysmal Atrial Fibrillation Clinical Trial
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling, Phase IV
Updated: 3/21/2012
mi
from
Rochester, NY
Click here to add this to my saved trials
Paroxysmal Atrial Fibrillation Clinical Trial
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling, Phase IV
Updated: 3/21/2012
mi
from
Cleveland, OH
Click here to add this to my saved trials
Paroxysmal Atrial Fibrillation Clinical Trial
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling, Phase IV
Updated: 3/21/2012
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Occult Paroxysmal Atrial Fibrillation in Patients With Non-cardioembolic Ischemic Stroke of Determined Mechanism
Status: Enrolling
Updated: 8/4/2011
mi
from
Chicago, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
AMPLATZER Cardiac Plug Clinical Trial
Status: Enrolling
Updated: 11/15/2013
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
AMPLATZER Cardiac Plug Clinical Trial
Status: Enrolling
Updated: 11/15/2013
mi
from
Aventura, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
AMPLATZER Cardiac Plug Clinical Trial
Status: Enrolling
Updated: 11/15/2013
mi
from
Detroit, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
AMPLATZER Cardiac Plug Clinical Trial
Status: Enrolling
Updated: 11/15/2013
mi
from
Louisville, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
AMPLATZER Cardiac Plug Clinical Trial
Status: Enrolling
Updated: 11/15/2013
mi
from
Portland, OR
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
AMPLATZER Cardiac Plug Clinical Trial
Status: Enrolling
Updated: 11/15/2013
mi
from
St. Cloud, MN
Click here to add this to my saved trials
Paroxysmal Atrial Fibrillation Clinical Trial
Use of the Hansen Medical System in Patients With Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 8/31/2015
mi
from
Austin, TX
Click here to add this to my saved trials
Paroxysmal Atrial Fibrillation Clinical Trial
Use of the Hansen Medical System in Patients With Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 8/31/2015
mi
from
Greenville, SC
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Continued Access to PREVAIL (CAP2)
Status: Enrolling
Updated: 11/4/2013
mi
from
Lexington, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Status: Enrolling
Updated: 11/30/2015
mi
from
Orlando, FL
Click here to add this to my saved trials
Persistent Atrial Fibrillation Clinical Trial
Efficacy and Safety Study of the Estech COBRA® Surgical System to Treat Patients With a History of Irregular Heart Beats
Status: Enrolling
Updated: 2/13/2013
mi
from
Kansas City, KS
Click here to add this to my saved trials
Persistent Atrial Fibrillation Clinical Trial
Efficacy and Safety Study of the Estech COBRA® Surgical System to Treat Patients With a History of Irregular Heart Beats
Status: Enrolling
Updated: 2/13/2013
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal AF
Status: Enrolling
Updated: 3/24/2014
mi
from
Birmingham, AL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal AF
Status: Enrolling
Updated: 3/24/2014
mi
from
Portland, ME
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal AF
Status: Enrolling
Updated: 3/24/2014
mi
from
Gainesville, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal AF
Status: Enrolling
Updated: 3/24/2014
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal AF
Status: Enrolling
Updated: 3/24/2014
mi
from
Wausau, WI
Click here to add this to my saved trials
Paroxysmal Atrial Fibrillation (PAF) Clinical Trial
Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)
Status: Enrolling, Phase IV
Updated: 1/13/2014
mi
from
Boston, MA
Click here to add this to my saved trials
Paroxysmal Atrial Fibrillation (PAF) Clinical Trial
Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)
Status: Enrolling, Phase IV
Updated: 1/13/2014
mi
from
Lancaster, PA
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/16/2015
mi
from
Nashville, TN
Click here to add this to my saved trials
Patients With Symptoms of Cardiac Arrhythmia at Risk for Atrial Fibrillation Clinical Trial
THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring
Status: Enrolling
Updated: 10/14/2015
mi
from
La Jolla, CA
Click here to add this to my saved trials
Paroxysmal Atrial Fibrillation Clinical Trial
Pilot Study Evaluating the Toray Satake Balloon Thermal Ablation System for Treatment of Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 7/17/2014
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Persistent Atrial Fibrillation Clinical Trial
Evaluation of the Phased Radio Frequency Ablation System
Status: Enrolling, Phase III
Updated: 12/3/2015
mi
from
Atlanta, GA
Click here to add this to my saved trials
Persistent Atrial Fibrillation Clinical Trial
Evaluation of the Phased Radio Frequency Ablation System
Status: Enrolling, Phase III
Updated: 12/3/2015
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Persistent Atrial Fibrillation Clinical Trial
Evaluation of the Phased Radio Frequency Ablation System
Status: Enrolling, Phase III
Updated: 12/3/2015
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Persistent Atrial Fibrillation Clinical Trial
Evaluation of the Phased Radio Frequency Ablation System
Status: Enrolling, Phase III
Updated: 12/3/2015
mi
from
Atlanta, GA
Click here to add this to my saved trials
Persistent Atrial Fibrillation Clinical Trial
Evaluation of the Phased Radio Frequency Ablation System
Status: Enrolling, Phase III
Updated: 12/3/2015
mi
from
Neptune, NJ
Click here to add this to my saved trials
Persistent Atrial Fibrillation Clinical Trial
Evaluation of the Phased Radio Frequency Ablation System
Status: Enrolling, Phase III
Updated: 12/3/2015
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Persistent Atrial Fibrillation Clinical Trial
Evaluation of the Phased Radio Frequency Ablation System
Status: Enrolling, Phase III
Updated: 12/3/2015
mi
from
St. Paul, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Stroke Feasibility Study
Status: Enrolling, Phase I, II
Updated: 12/1/2014
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Postoperative Atrial Fibrillation Clinical Trial
Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation
Status: Enrolling, Phase III
Updated: 4/29/2015
mi
from
Atlanta, GA
Click here to add this to my saved trials
Postoperative Atrial Fibrillation Clinical Trial
Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation
Status: Enrolling, Phase III
Updated: 4/29/2015
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Postoperative Atrial Fibrillation Clinical Trial
Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation
Status: Enrolling, Phase III
Updated: 4/29/2015
mi
from
Asheville, NC
Click here to add this to my saved trials
Postoperative Atrial Fibrillation Clinical Trial
Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation
Status: Enrolling, Phase III
Updated: 4/29/2015
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Persistent Atrial Fibrillation Clinical Trial
Comparison of Reverse Remodeling and PVI Versus CFAE and/or Linear Lesions and PVI for Persistent AF
Status: Enrolling, Phase IV
Updated: 6/10/2013
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation
Status: Enrolling, Phase III
Updated: 4/20/2015
mi
from
Cleveland, OH
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation
Status: Enrolling, Phase III
Updated: 4/20/2015
mi
from
Columbus, OH
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation
Status: Enrolling, Phase III
Updated: 4/20/2015
mi
from
Lexington, KY
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation
Status: Enrolling, Phase III
Updated: 4/20/2015
mi
from
Morristown, NJ
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation
Status: Enrolling, Phase III
Updated: 4/20/2015
mi
from
Murray, UT
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation
Status: Enrolling, Phase III
Updated: 4/20/2015
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation
Status: Enrolling, Phase III
Updated: 4/20/2015
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Comparison of CTI Ablation Prior to or After LA Ablation for AF
Status: Enrolling, Phase III
Updated: 12/24/2014
mi
from
New York, NY
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
PaTH Clinical Data Research Network (CDRN) Atrial Fibrillation (AF) Clinician-Patient Partnership Cohort
Status: Enrolling
Updated: 11/30/2015
mi
from
Baltimore, MD
Click here to add this to my saved trials
Ischemic Stroke Clinical Trial
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Status: Enrolling
Updated: 10/19/2015
mi
from
Manhasset, NY
Click here to add this to my saved trials
Paroxysmal Atrial Fibrillation Clinical Trial
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 1/15/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)
Status: Enrolling, Phase IV
Updated: 3/23/2016
mi
from
Worcester, MA
Click here to add this to my saved trials
Paroxysmal Atrial Fibrillation Clinical Trial
Oral Anticoagulation Therapy Pilot Study
Status: Enrolling, Phase IV
Updated: 1/12/2016
mi
from
Austin, TX
Click here to add this to my saved trials
Paroxysmal Atrial Fibrillation Clinical Trial
Oral Anticoagulation Therapy Pilot Study
Status: Enrolling, Phase IV
Updated: 1/12/2016
mi
from
Cleveland, OH
Click here to add this to my saved trials
Paroxysmal Atrial Fibrillation Clinical Trial
Oral Anticoagulation Therapy Pilot Study
Status: Enrolling, Phase IV
Updated: 1/12/2016
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
Status: Enrolling
Updated: 1/13/2016
mi
from
Boston, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)
Status: Enrolling
Updated: 1/14/2016
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)
Status: Enrolling
Updated: 1/14/2016
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)
Status: Enrolling
Updated: 1/14/2016
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery
Status: Enrolling, Phase I, II
Updated: 1/25/2016
mi
from
Durham, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
Status: Enrolling, Phase IV
Updated: 2/1/2016
mi
from
Raleigh, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
Status: Enrolling, Phase IV
Updated: 2/1/2016
mi
from
St. Louis, MO
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers
Status: Enrolling, Phase I
Updated: 2/11/2016
mi
from
Austin, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Richmond, VA
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Substrate Versus Trigger Ablation for Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 3/1/2016
mi
from
San Diego, CA
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Status: Enrolling, Phase IV
Updated: 3/15/2016
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Status: Enrolling, Phase IV
Updated: 3/15/2016
mi
from
Austin, TX
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Status: Enrolling, Phase IV
Updated: 3/15/2016
mi
from
Bloomington, IN
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Status: Enrolling, Phase IV
Updated: 3/15/2016
mi
from
Columbia, MO
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Status: Enrolling, Phase IV
Updated: 3/15/2016
mi
from
Elkhart, IN
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Status: Enrolling, Phase IV
Updated: 3/15/2016
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Status: Enrolling, Phase IV
Updated: 3/15/2016
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Status: Enrolling, Phase IV
Updated: 3/15/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Status: Enrolling, Phase IV
Updated: 3/15/2016
mi
from
Huntsville, AL
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Status: Enrolling, Phase IV
Updated: 3/15/2016
mi
from
La Jolla, CA
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Status: Enrolling, Phase IV
Updated: 3/15/2016
mi
from
Linden, NJ
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Status: Enrolling, Phase IV
Updated: 3/15/2016
mi
from
Norwalk, CT
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Status: Enrolling, Phase IV
Updated: 3/15/2016
mi
from
Plano, TX
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Status: Enrolling, Phase IV
Updated: 3/15/2016
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Status: Enrolling, Phase IV
Updated: 3/15/2016
mi
from
San Antonio, TX
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Status: Enrolling, Phase IV
Updated: 3/15/2016
mi
from
San Antonio, TX
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 16